|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02506 XUNFEIHEALTH
Nominal 
79.500 +8.250 (+11.579%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 446,116 | 49.427% | 914,993 | 733,984 | 556,125 | 471,860 |
| Cost of Sales | (210,005) | 45.147% | (453,349) | (329,900) | (241,471) | (241,191) |
| Gross Profit | 236,111 | 53.450% | 461,644 | 404,084 | 314,654 | 230,669 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (13,681) | 329.950% | (35,525) | (13,404) | (6,187) | (8,602) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (38,231) | (3,901) | (1,440) | |
| Share of Results of Asso. & JCEs | (5,545) | -- | (2,858) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (67,624) | -32.466% | (95,985) | (172,016) | (186,915) | (244,100) | |
| Taxation | 19,524 | 9.329% | 30,218 | 34,380 | 32,691 | 35,505 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (11,203) | -- | 979 | 5,036 | 9,382 | 19,195 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (59,303) | -19.954% | (64,788) | (132,600) | (144,842) | (189,400) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,454 | -7.574% | 293 | (278) | (6,749) | (2,547) |
| Depreciation & Amortisation | 37,202 | 78.111% | 49,240 | 47,925 | 41,960 | 54,232 |
| Directors' Emoluments | 2,440 | -63.270% | 11,187 | 19,048 | 29,425 | 29,402 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -49.000 | -19.672% | -54.000 | -116.000 | -130.000 | -171.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.355) | (1.178) | (2.829) | (1.026) |
| NBV per share ($) | 7.087 | -- | 7.417 | 7.776 | -- | -- |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -59,303 |
| %Change | -19.954% |
| EPS / (LPS) | RMB -0.490 |
| NBV Per Share (¥) | RMB 7.087 |